We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.80 | 0.58% | 485.40 | 485.30 | 485.50 | 486.30 | 482.20 | 482.50 | 1,877,687 | 15:28:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3962 | 12.25 | 13.29B |
Date | Subject | Author | Discuss |
---|---|---|---|
17/2/2021 09:56 | The markets have changed as you know rc digital has transformed a new era in markets,you have to keep an eye on your stock regular if not your gonna lose yer money more than making a dime trading or investing,this isn’t the 70s or 80s Anymore I’ve only been doing this 14year and half the companies I bought shares in 2006 don’t exist | linton5 | |
17/2/2021 09:45 | A lot of people who buy shares are very short term. And they seem to be the type of people that have accounts at places like advfn. Only someone with a short term outlook would need to see live prices. Hence the boards here tend to have a higher percentage of such people. I bet if you look at those who hold long term they don't even bother with sites like advfn. | rcturner2 | |
17/2/2021 09:19 | agree entirely | eurofox | |
17/2/2021 08:42 | I don't understand why anyone would want to sell Aviva right now. I know I'm in a sweet position having bought initially at 258 with this being well over half of my holding. I could take substantial profits but wont because of the following reasons: I dont know the 'normal' trading range yet, either post Covid or post sell off. I'm sitting on a progressive 8% dividend while I wait to see the effect of AB's efforts. And I'm actually excited to see what happens to all that capital. Why anybody would sell now - even if I'd have bought at plus 400 - is beyond me. | devonbeachbum | |
17/2/2021 08:17 | for my sins I have just dipped my toe in GSK, but without selling any here | eurofox | |
17/2/2021 08:03 | I've both but feel more comfortable currently here. spud | spud | |
16/2/2021 17:30 | Sold my trading acc. Aviva for a small profit and bought Glaxo. Still keeping main holding. | whatsup32 | |
16/2/2021 16:09 | Phew!!! added a few more at 358p as the momentum looks positive and any correction rather restricted given news ahead. Best wishes. | cyberian | |
16/2/2021 13:47 | My apologies if I forgot anyone sorry | linton5 | |
16/2/2021 13:41 | Linton5,you forgot to mention chinese investor! | imagining | |
16/2/2021 13:01 | Yip great work spud glad we have you intellectual guys onboard here euro,wba,cjacs keep up the good work.🙏 | linton5 | |
16/2/2021 12:46 | Thanks spud. | spcecks | |
16/2/2021 12:32 | Thanks spud , interesting times ahead | whatsup32 | |
16/2/2021 11:58 | Macif emerges as favourite to buy $3.6bn Aviva France unit (MENAFN - Gulf Times) Aviva Plc, the British insurer, is in advanced talks on a sale of its Italian operations as it pushes ahead with about €6bn ($7.3bn) of divestments, people with knowledge said. The UK company is in negotiations to sell its Italian life insurance business to Paris-based CNP Assurances, according to the people, who asked not to be identified because the information is private. Allianz SE is in talks to acquire Aviva's general insurance unit in the country, the people said. A deal could be reached within a few weeks, the people said. The two disposals in Italy could fetch more than €1bn combined, the people said. Shares of Aviva rose as much as 3.1% in morning trading yesterday. They were up 2.8% at 9:49am in London, on track for the highest close in almost a year, while the benchmark FTSE 100 Index gained 1.4%. No final agreements have been reached, and discussions could still fall apart, they said. The sale is part of Aviva chief executive officer Amanda Blanc's plan to improve the London-listed insurer's struggling share price by offloading non-core assets. Blanc has wasted little time since taking the helm in July, agreeing to sell a majority stake in its Singapore business for about $2bn and pushing ahead with the disposal of its units in Poland and Italy. She's also exploring options for Aviva's joint venture in Turkey. Meanwhile, French mutual insurer Macif has emerged as the frontrunner to acquire Aviva's insurance operations in the country, the people said. Macif is seen as the most suitable buyer for the unit, which could fetch more than €3bn, because it's a local player, the people said. Macif is competing against French private equity firm Eurazeo SE, said the people. Eurazeo was a latecomer to the auction and there could be some hesitation to sell to private equity, they said. For Macif, a purchase of Aviva France would be its biggest-ever deal. Eurazeo has been holding talks with Italy's Assicurazioni Generali SpA about potentially teaming up, the people said. Eurazeo, one of Europe's few listed buyout firms, sees Aviva France as a strategic investment that would elevate its €18.8bn in assets under management, according to one person. Eurazeo, led by Virginie Sarah Morgon, has a market value of €4.9bn. A consortium of Allianz and Athora has been sidelined due to resistance to the latter firm's links to American private equity, the people said. Private equity firms buy life insurers to attract permanent capital in a bid to diversify from buyout strategies. They invest the cash flows from policies into illiquid assets to boost returns and cut costs by boosting scale. Aviva, which hasn't yet decided on a winner, could reach an agreement as early as this month, the people said. The French business generated £13.4bn ($18.5bn) of revenue in 2019, about 20% of the group's total, according to data compiled by Bloomberg. Allianz, Generali and Dutch insurer NN Group NV are among parties that expressed interest in Aviva's Polish business, which could fetch about €1.5bn to €2bn, the people said. Representatives for Allianz, Athora, Aviva, CNP, Eurazeo, Generali and Macif declined to comment. A spokesperson for NN couldn't immediately be reached. Mergers and acquisitions in the European insurance industry are being driven by companies looking to bulk up their property and casualty businesses while selling interest-rate dependent life units. Insurance deals worth $64bn have been struck in the region during the last 12 months, according to data compiled by Bloomberg. That's up 62% year-on-year, the data show. spud | spud | |
16/2/2021 11:55 | Lets hope the sales are going to be sooner than later as the GBP£ has been strengthening añd IMHO has someway to go against the EURO in particular. It would be interesting to know if the BOD have been hedging the currency exposure. | mark1000 | |
15/2/2021 23:05 | Interesting article from Gulf Times today looking at progress of Aviva sales of Italy, France and Poland. All expected to be confirmed within 2 weeks. Put together with Singapore Sale the proceeds are suggested to amount to 8 Billion Euro. If that cash realisation doesn’t boost the share price beyond £5 then nothing will. | brilltrader | |
15/2/2021 22:46 | Sorry to hear of your losses Eurofox, and I don't want to promote non Aviva talk on this BB, but I feel I must comment on both your and Lintons remarks re hospitals. While it is undeniable that Covid has been contacted in hospitals it can be caught almost anywhere. For your information I work as a Senior Stock Controller for General Theatres in a medium sized DGH. I know that lots of non essential ops (mainly Elective surgery) has been cancelled. Our Cancer services and Urology ops have been moved to a local private hospital and a community hospital respectively. The remaining main site has been split into zones so that Covid zones are nowhere near non Covid areas. We even have Covid and non Covid ICU's. Only essential emergency surgery has been continued. And Ive seen sores on ODP's faces for having to wear tight fitting FFP3 masks for so long. While I can only report what I see, I can assure you that the Trust I work for, and probably many others up and down the country, are taking as many steps as they can to eliminate risk as best they can. | devonbeachbum | |
15/2/2021 19:05 | Thanks Spud. Its the right thread. | scobak | |
15/2/2021 18:04 | Yes I’ve heard of so many people catching Covid in hospital it’s unbelievable over 10k people have died catching Covid there I’d be terrified if I was going in for a Routine operation,that is just not right | linton5 | |
15/2/2021 16:47 | Things usually come in 3's so all clear from now on. Some big trades today, they must be largely buys. Hope patience is about to be rewarded. | dekle | |
15/2/2021 16:43 | Pretty bad luck - they say things come in threes (not only London busses) - but better than the outcomes for 3 of my friends who have now sadly died of covid, having gone into hospital covid-free and ended up contracting it in hospital. | eurofox | |
15/2/2021 16:33 | Yes thank you eurofox for your kind concerns,I’m getting my mojo back and great to see green grass again,your gonna laugh at this I crashed my car on Wednesday approaching a roundabout at 15mph put my breaks on gently as bus coming onto it from other side my car just kept going (black ice) and went into the bus.car is agoner I think away to get assessed.so I don’t feel very lucky 💩worst run I’ve ever had as had 2 other issues last 2 month regarding my phone and house. It’s like 1 hour at a time not 1day😹 | linton5 | |
15/2/2021 16:28 | What price targets have we here. | leedslad001 | |
15/2/2021 16:25 | Hi Linton5, hope you are feeling much better now. | eurofox |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions